- Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial News-Medical.Net
- Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside Yahoo Finance
- View Full coverage on Google News
Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial – News-Medical.Net
ByGoogle News
Aug 10, 2020